Pharmaceutical manufacturers of Morphine sulfate

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 80 billion doses of nearly 8,000 products annually. Its rapidly growing expert workforce exceeds 18,000, including more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, Catalent, Inc. (NYSE:CTLT), is in S&P 500® company, and generated nearly $5 billion in revenue in its 2022 fiscal year.

Euroapi focuses on revolutionizing active component solutions to sustainably fulfill the demands of clients and patients globally. As a prominent figure in active pharmaceutical ingredients, we possess a comprehensive portfolio of around 200 products, encompassing a wide range of technologies, and are constantly developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO). Our 3,350 employees are driven by the commitment to improving access to essential therapies and promoting health

Siegfried serves as your favored associate for comprehensive integrated pharmaceutical ingredient and drug product services with manufacturing capabilities globally. Our expertise is crucial for your venture throughout the entire lifespan. Our enthusiasm lies in creating and producing formulations. It is extraordinary for a provider of development and manufacturing services to possess such a blend of inherent technical expertise and knowledge. Pharmaceutical ingredient services entail Tailored Development and Outsourced Manufacturing for both active pharmaceutical ingredients (API) and intermediates, along with our own range of API (opiates and other regulated substances) and documentation featuring independent patented technologies. Clients utilizing our drug product services benefit from a wealth of inherited expertise in intricate oral drug delivery systems, including sterile filling, backed by in-house development, customer development and manufacturing, and a wide array of completed dosage form products. Enhancing chemical processes and formulations is our area of specialization. We collaborate closely with clients to innovate and enhance chemical processes, thus providing additional benefits and value. Siegfried operates at 11 locations globally, spanning both the Eastern and Western Hemispheres, with multi-purpose cGMP chemical manufacturing facilities in Zofingen, Switzerland; Pennsville, New Jersey, USA; Nantong, China; Minden, Germany; Saint-Vulbas, France; Evionnaz, Switzerland; and sites for manufacturing drug products in Zofingen, Switzerland; Malta; Hameln, Germany, Irvine, USA; Barberà del Vallès, Spain and El Masnou, Spain. Count on Siegfried as your preferred partner for more opportunities.

Veranova boasts over 50 years of expertise and is a frontrunner in the creation and fabrication of intricate and specialized APIs for the pharmaceutical and biotech sectors. It was previously a segment of Johnson Matthey, specializing in intricate and regulated chemical processes. The company delivers customized services throughout all phases of drug development and is split into Generics and Originators. It possesses a variety of development technologies and areas of expertise, along with a cooperative approach to API manufacturing and procedures.

MNK’s Specialty Generics division provides a wide variety of high-quality generic medications, focusing on pain relief, addiction treatment, and ADHD, as well as a comprehensive range of active pharmaceutical ingredients (APIs), such as acetaminophen/paracetamol, DEA scheduled compounds, and stearates. We run the largest API facility in the United States. Discover the range of excipients available from Mallinckrodt Pharmaceuticals for use in pharmaceutical drug delivery systems (DDS).

Established in 1997, Temad Co. has been operating for over two decades and is recognized as one of the leading manufacturers of APIs in Iran. It is also known for its groundbreaking production of both narcotic and non-narcotic products with exceptional quality within the Middle East. In addition to adhering to Iranian GMP regulations, Temad has met the national and international standards of API manufacturing, including ISO 9001/14001/17025/45001 and OHSAS 18001. With a portfolio of over 115 pharmaceutical products, Temad ensures compliance with GMP and WHO standards as well as regulations for both narcotic and non-narcotic medications. The company proudly exports its diverse range of products to 45 countries across the globe.

Pluvia Consumer Health operates as a multinational pharmaceutical firm and is headquartered in Istanbul, Turkey. The company possesses unique molecules and expertise. Its product portfolio comprises distinct APIs and Finished Dosage Form medications focusing on opioid medications, cosmeceuticals, and nutraceutical supplements, all supported by modern processing systems. The company's ability to manufacture its products in-house, leveraging its proprietary know-how from A to Z, enables it to provide comprehensive support in documentation, formulation, and scientific matters, as well as supply high-quality products at unbeatable prices, covering various types of APIs.

Founded in 1932 in Milan, it was the first company authorised to process opiates for the pharmaceutical industry. Even today it is the only manufacturing company (authorized to produce narcotic substances) existing in our country. Our goal is to produce active pharmaceutical ingredients respecting the highest quality standards aimed at pain therapy. At every stage of the production process we strive to optimize resources, maintain a high level of quality and follow the indications dictated by the regulations in force.

Verve Human Care Laboratories is the premier Pharmaceutical Finished Formulation Manufacturer and Exporter in the field of analgesics and anesthesia in India. Specializing in Narcotic and Psychotropic Products, our production facility adheres to the standards set by US-FDA and PIC/S guidelines. Our current approvals include WHO-GMP, TFDA-Tanzania, PMPB-Malawi, FDA Ghana, PPB-Kenya, NDA-Uganda, FMHACA-Ethiopia, SFDA-Saudi Arabia, MOH-Cambodia, MCAZ-Zimbabwe with ongoing approval processes in many other countries.

Aradigm is actively involved in fulfilling the commitment to developing inhalation medication products that could potentially transform the quality of life for patients with severe pulmonary conditions. Since 1991, the organization has assembled an exceptional group of researchers, technicians, and medical specialists who have been leading the way in the creation of innovative inhalation delivery products. This team, for instance, spearheaded the AERx® pulmonary delivery platform, which underwent testing in numerous patients using various medications and biologics such as insulin, fentanyl, erythropoietin, and nicotine.